Pro Medicus Ltd
PME: XASX (AUS)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
A$22.00 | Txqldpb | Fmrtjwzc |
Pro Medicus: Massive New Contract Win but Shares Remain Expensive
We raise our fair value estimate for narrow-moat Pro Medicus by 8% to AUD 33.50. The majority of our upgrade was due to an uplift in Pro Medicus’ contracted revenue following a significant contract win and roughly 25% due to a stronger U.S. dollar.